These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1133 related articles for article (PubMed ID: 30811764)
21. Long non-coding RNA MFSD4A-AS1 promotes lymphangiogenesis and lymphatic metastasis of papillary thyroid cancer. Liu X; Zhang C; Wang X; Cui C; Cui H; Zhu B; Chen A; Zhang L; Xin J; Fu Q; Dionigi G; Sun H Endocr Relat Cancer; 2023 Mar; 30(3):. PubMed ID: 36606578 [TBL] [Abstract][Full Text] [Related]
22. Overexpression of serum lncRNA-ABHD11-AS1 as poor prognosis of patients with papillary thyroid carcinoma. Hou S; Zhuang YY; Lin QY; Chen Z; Zhao HG; Zhang L; Lin CH Exp Mol Pathol; 2021 Aug; 121():104658. PubMed ID: 34102210 [TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA AGAP2-AS1 promotes proliferation and metastasis in papillary thyroid cancer by miR-628-5p/KLF12 axis. Xu C; Shao Y; Liu J; Yao X; Quan F; Zhao Q; Zhao R; Kou B; Li H; Han P; Wang X; Bai Y; Zheng Z; Zhang S J Bioenerg Biomembr; 2021 Apr; 53(2):235-245. PubMed ID: 33604734 [TBL] [Abstract][Full Text] [Related]
24. LncRNA HOXA-AS2 Facilitates Tumorigenesis and Progression of Papillary Thyroid Cancer by Modulating the miR-15a-5p/HOXA3 Axis. Jiang L; Wu Z; Meng X; Chu X; Huang H; Xu C Hum Gene Ther; 2019 May; 30(5):618-631. PubMed ID: 30375256 [TBL] [Abstract][Full Text] [Related]
25. Altered expression of DLG1-AS1 distinguished papillary thyroid carcinoma from benign thyroid nodules. He T; Wang H; Sun J; Wu J; Gong F; Li S; Wang H; Li Y BMC Endocr Disord; 2019 Nov; 19(1):122. PubMed ID: 31718630 [TBL] [Abstract][Full Text] [Related]
26. Long non-coding RNA OIP5-AS1 serves as a competing endogenous RNA to modulate X-linked inhibitor of apoptosis protein expression via adsorbing miR-429 in papillary thyroid cancer. Yu CS; Wang YB; Li Q; Yang EL; Dong BB J Biol Regul Homeost Agents; 2021; 35(3):909-920. PubMed ID: 34155880 [TBL] [Abstract][Full Text] [Related]
27. LncRNA TTN-AS1 promotes migration, invasion, and epithelial mesenchymal transition of lung adenocarcinoma via sponging miR-142-5p to regulate CDK5. Jia Y; Duan Y; Liu T; Wang X; Lv W; Wang M; Wang J; Liu L Cell Death Dis; 2019 Jul; 10(8):573. PubMed ID: 31363080 [TBL] [Abstract][Full Text] [Related]
28. LncRNA XIST Promotes Migration and Invasion of Papillary Thyroid Cancer Cell by Modulating MiR-101-3p/CLDN1 Axis. Du YL; Liang Y; Cao Y; Liu L; Li J; Shi GQ Biochem Genet; 2021 Apr; 59(2):437-452. PubMed ID: 33057875 [TBL] [Abstract][Full Text] [Related]
29. MicroRNA-26a suppresses the malignant biological behaviors of papillary thyroid carcinoma by targeting ROCK1 and regulating PI3K/AKT signaling pathway. Wu YC; Li SY; Jia YF Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8940-8949. PubMed ID: 31696481 [TBL] [Abstract][Full Text] [Related]
30. lncRNA DUXAP8 inhibits papillary thyroid carcinoma cell apoptosis via sponging the miR‑20b‑5p/SOS1 axis. Pang R; Yang S Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760128 [TBL] [Abstract][Full Text] [Related]
31. LncRNA TTN-AS1/miR-134-5p/PAK3 axis regulates the radiosensitivity of human large intestine cancer cells through the P21 pathway and AKT/GSK-3β/β-catenin pathway. Zuo Z; Ji S; He L; Zhang Y; Peng Z; Han J Cell Biol Int; 2020 Nov; 44(11):2284-2292. PubMed ID: 32749739 [TBL] [Abstract][Full Text] [Related]
32. Long noncoding RNA LINC00520 accelerates progression of papillary thyroid carcinoma by serving as a competing endogenous RNA of microRNA-577 to increase Sphk2 expression. Sun Y; Shi T; Ma Y; Qin H; Li K Cell Cycle; 2020 Apr; 19(7):787-800. PubMed ID: 32075502 [TBL] [Abstract][Full Text] [Related]
33. LncRNA PROX1-AS1 promotes proliferation, invasion, and migration in papillary thyroid carcinoma. Shen Y; Xia E; Bhandari A; Wang X; Guo G Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30061172 [TBL] [Abstract][Full Text] [Related]
34. Long noncoding RNA TTN-AS1 promotes the proliferation and migration of prostate cancer by inhibiting miR-1271 level. Zhu Y; Yang Z; Luo XH; Xu P Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10678-10684. PubMed ID: 31858535 [TBL] [Abstract][Full Text] [Related]
35. TTN-AS1 delivered by gastric cancer cell-derived exosome induces gastric cancer progression through in vivo and in vitro studies. Wang Y; Jiang R; Zhao H; Li F; Li Y; Zhu M Cell Biol Toxicol; 2023 Apr; 39(2):557-571. PubMed ID: 36214926 [TBL] [Abstract][Full Text] [Related]
36. LncRNA CCND2-AS1 promotes proliferation, migration, and invasion in papillary thyroid carcinoma. Xia E; Bhandari A; Shen Y; Zhou X; Sindan N; Xiang J; Guan Y; Yang F; Wang O Biochem Biophys Res Commun; 2018 Feb; 496(2):628-632. PubMed ID: 29366479 [TBL] [Abstract][Full Text] [Related]
37. LncRNA RHPN1-AS1 Promotes Cell Proliferation, Migration and Invasion Through Targeting miR-7-5p and Activating PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma. Song XZ; Ren XN; Xu XJ; Ruan XX; Wang YL; Yao TT Technol Cancer Res Treat; 2020; 19():1533033820957023. PubMed ID: 32910747 [TBL] [Abstract][Full Text] [Related]
38. LncRNA FAM230B promotes the metastasis of papillary thyroid cancer by sponging the miR-378a-3p/WNT5A axis. Zhou Q; Feng J; Yin S; Ma S; Wang J; Yi H Biochem Biophys Res Commun; 2021 Mar; 546():83-89. PubMed ID: 33578293 [TBL] [Abstract][Full Text] [Related]
39. LncRNA LINC00460 promotes the papillary thyroid cancer progression by regulating the LINC00460/miR-485-5p/Raf1 axis. Li G; Kong Q Biol Res; 2019 Dec; 52(1):61. PubMed ID: 31870440 [TBL] [Abstract][Full Text] [Related]